Boothbay Fund Management, LLC Mustang Bio, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $15,349 - $29,904	-26,464 Reduced 54.86%	21,774 $13,000
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $51,522 - $67,099	-19,970 Reduced 29.28%	48,238 $130,000
Q4 2020 Feb 12, 2021	SELL	$2.66 - $4.18 $256,341 - $402,822	-96,369 Reduced 58.56%	68,208 $258,000
Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $332,571 - $428,697	110,489 Added 204.28%	164,577 $518,000
Q1 2020 May 15, 2020	SELL	$1.91 - $4.52 $1,910 - $4,520	-1,000 Reduced 1.82%	54,088 $145,000
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.08 $141,576 - $224,759	55,088 New	55,088 $225,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.